Last updated: May 29, 2026
TYBLUME suppliers: who manufactures and supplies this pharmaceutical product (US)
TYBLUME supply chain depends on the drug’s specific dosage form and market authorization holder. No supplier list can be produced from the information provided.
What companies supply TYBLUME and who manufactures it?
A “supplier” answer requires the exact TYBLUME product definition (active ingredient, strength, dosage form, marketing authorization holder, and US label configuration) and then mapping those entities to manufacturing and commercial supply roles.
Which manufacturer sites produce TYBLUME?
Mapping manufacturing sites requires linking TYBLUME to:
- the approved label
- the FDA application referenced by the label (NDA/BLA/ANDA/505(b)(2))
- the manufacturing information in the FDA submission
- any contract manufacturing and packager disclosures in the label and regulatory filings
Who is the commercial supplier or distributor for TYBLUME?
Distributor and commercial supply roles come from:
- the marketed label and package labeling
- wholesaler/distributor listings
- wholesaler catalog entries
- FDA drug establishment registration for TYBLUME-labeled finished products
What patents or exclusivity affect TYBLUME supply and generic entry?
A supply-chain-to-competition map requires the product’s legal status:
- Orange Book listings (if an ANDA exists)
- patent expiration and exclusivity periods
- any Paragraph IV litigation and settlements that constrain manufacturing and distribution
Is TYBLUME an NDA, 505(b)(2), or ANDA product?
That determination is necessary to identify:
- the regulatory sponsor
- the upstream API and intermediate suppliers disclosed through the application
- whether supply is tied to a single source due to formulation, process, or testing IP
What is the Orange Book status of TYBLUME?
Orange Book status determines:
- whether TYBLUME is listed under an NDA with blocking patents
- whether there are listed method, composition, and formulation patents
- which applicants are attempting approval via ANDA or 505(b)(2)
Which patents protect TYBLUME drug substance and drug product?
That requires an Orange Book patent family pull tied to the exact TYBLUME submission number(s), claim types, and expiration dates.
Who supplies API for TYBLUME and what are the upstream contract manufacturers?
Upstream sourcing depends on:
- API DMF references (if applicable)
- the labeled manufacturer disclosures for the drug substance and drug product
- FDA drug establishment registration and inspection records by establishment
Which API DMFs back TYBLUME?
Identifying DMFs requires:
- the NDA/BLA/ANDA application crosswalk
- the DMF holder names and referenced synthesis routes
- any additional suppliers listed in CMC supplements
How do TYBLUME formulation or process patents constrain manufacturing?
If TYBLUME has formulation, polymorph, or process patents, that can restrict:
- generic development
- manufacturing scale-up
- equivalency testing strategies
- contract manufacturing participation due to license or infringement risk
What manufacturing/IP barriers affect TYBLUME CMO selection?
This is derived from:
- process patents and method-of-use claims tied to manufacturing
- consent decrees, settlements, or licensing agreements
- site-specific approval and validation constraints
What FDA regulatory pathway applies to TYBLUME and how does it affect sourcing?
The pathway determines the disclosure depth for:
- manufacturing controls
- batch release testing
- comparability requirements
- permitted change categories (supplier transfers, scale changes)
Does TYBLUME rely on a single approved facility or multiple validated sites?
That requires facility-specific labeling and FDA CMC records.
Which suppliers are most likely in TYBLUME’s supply chain?
No ranked supplier list can be produced without the exact TYBLUME product identity and its regulatory dossier mapping.
Key Takeaways
- A “TYBLUME suppliers” list cannot be generated from the provided information.
- Supplier identification requires mapping the marketed TYBLUME product to its FDA regulatory entry and then extracting listed manufacturers, distributors, and (where disclosed) API sources.
FAQs
- How can I identify the finished dose manufacturer for TYBLUME?
- Where do I find the API supplier or DMF holder for TYBLUME?
- Is TYBLUME single-sourced, and what are the FDA indicators?
- Do TYBLUME’s patents or exclusivity delay generic manufacturing?
- What Orange Book listings should be checked for TYBLUME supplier risk?
References
No sources were cited.
